CEO, Medicare Advantage · CLOVER HEALTH INVESTMENTS, CORP. /DE · Class A Common Stock
Side
SELL
Value
$12K
Shares
4,597
Price
$2.58
Executed
Jan 20, 2026
Disclosed
Jan 20, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jan 20 executedJan 20, 2026 disclosed
CLOV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Reynoso Jamie L. filed this Form 4 reporting a open-market sale of CLOV on Jan 20, 2026. It became public on Jan 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CEO, Medicare Advantage
Reynoso Jamie L.cik:0001839066
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DEcik:0001801170
Revision history · 0
No field has changed since this record was first ingested.
